HEALTHX305.00

Health X Platform Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersSURAKSHAKRSNAANEPHROPLUS3BBLACKBIOMcap ₹970 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,375.71,111.01,319.31,467.7
Other Income60.459.858.345.7
Total Income1,436.11,170.81,377.51,513.4
Expenses
+ Cost of Materials Consumed2.01.70.80.7
+ Purchases of Stock-in-Trade1,167.61,015.81,248.91,436.6
+ Changes in Inventories63.2-0.1-41.3-80.5
+ Employee Benefit Expense49.049.884.094.3
+ Finance Costs1.00.20.81.3
+ Depreciation & Amortisation9.15.86.67.3
+ Other Expenses88.599.879.083.0
Total Expenses1,380.41,173.01,378.81,542.8
EBITDA5.4-56.0-52.1-66.5
EBIT-3.7-61.9-58.7-73.9
Profit
PBT before Exceptional Items55.7-2.2-1.2-29.4
+ Exceptional Items0.0-190.6-1.1-1.1
Pretax Income55.7-192.9-2.4-30.6
+ Current Tax-12.84.10.81.0
+ Deferred Tax-23.6-74.3-1.7-5.5
Tax Expense-36.4-70.1-0.9-4.5
+ Share of Associates & JVs-86.2-10.80.00.0
Net Income5.9-133.5-1.4-26.1
+ Net Income — Continuing Ops92.0-122.7-1.4-26.1
+ Other Comprehensive Income0.1-0.42.21.3
Total Comprehensive Income6.0-134.00.7-24.7
Net Income to Common8.9-91.21.2-20.2
Minority Interest-3.0-42.4-2.6-5.9
Per Share
Basic EPS2.79-28.660.37-6.35
Diluted EPS2.79-28.660.37-6.35
Revenue Detail — as filed
+ Sale of Products1,351.71,085.01,303.51,465.2
+ Sale of Services3.03.12.42.5
+ Dividend Income0.20.30.90.9
+ Net Gain on Fair Value Changes19.621.411.6-1.7
Other Comprehensive Income — detail
+ Other Comprehensive Income0.1-0.42.21.3
+ Items NOT to be Reclassified to P&L0.2-0.71.90.5
+ Tax on Items NOT to be Reclassified-0.20.40.1
+ Tax on Items NOT to be Reclassified — alt tag0.1
+ Items to be Reclassified to P&L0.9
+ Tax on Items to be Reclassified0.2
Comprehensive Income — Owners of Parent9.0-0.32.9-19.2
Comprehensive Income — Non-controlling Interests-3.0-0.1-2.1-5.6
Per Share — as-filed variants
Basic EPS — Continuing Operations2.79-28.660.37-6.35
Diluted EPS — Continuing Operations2.79-28.660.37-6.35
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit142.993.5110.9110.8
Gross Margin %10.398.428.407.55
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)55.7-2.2-1.2-29.4
− Exceptional Items (reconciliation)0.0-190.6-1.1-1.1
Net Income Adj (tax-effected)5.9-12.2-0.8-25.1
EPS Adj2.79-2.620.19-6.12
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Interest Earned0.70.80.80.8
Paid Up Equity Capital31.831.831.831.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.